当前位置: 首页 > 期刊 > 《第四军医大学学报》 > 2004年第9期
编号:10871701
老年乳腺癌患者术后早期应用泰索帝每周方案辅助化疗的耐受性分析
http://www.100md.com 《第四军医大学学报》 2004年第9期
乳腺癌,,乳腺癌;泰索帝;化疗;毒性反应,0引言,1对象和方法,2结果,3讨论,【参考文献】
     Tolerance of weekly scheduled administration of Doxetaxel in elder patients with breast cancer shortly after mammectomy

    HUANG Chen, YAO Qing, GAO JianYuan, LING Rui, ZHANG JuLiang

    1Department of Geriatrics, 2Department of Vascular and Endocrine Surgery, Xijing Hospital, Fourth Military Medical Univercity, Xi’an 710033, China

    【Abstract】 AIM: To discuss the tolerance of weekly scheduled administration of docetaxel in elder patients shortly following mammectomy. METHODS: Seventy elder patients with breast cancer were divided into 2 groups and Doxetaxel was administrated on the 3rd and 14th day respectively after operation. Healing of incision and response to chemotherapy were observed. RESULTS: There was no significant difference in incision healing between the two groups and the major sideeffects at the early stage of chemotherapy were nausea and vomiting, which were relieved after treatment. The occurrence rate of group A and B was 41.9% and 44.4%, respectively. I-II grade leucopenia was found at the late stage of chemotherapy and the occurrence rate of group A and B was 16.3% and 14.8%, respectively. There was no significant difference between the two groups and no other severe side effects were observed in both groups. CONCLUSION: The weekly scheduled administration of docetaxel in elder patients shortly following mammectomy is safe and well tolerated. ......

您现在查看是摘要页,全文长 7302 字符